Lothar Roessig
机构：Research Triangle Park Foundation, North Carolina Biotechnology Center
发表论文 114 篇 · 总被引 6572 次 · h-index 36
代表论文
- Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
- Cardiotropic AAV gene therapy for heart failure: a phase 1 trial (2025 · Nature Medicine · 被引 25)
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat (2024 · Clinical Pharmacokinetics · 被引 13)
- Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction (2024 · JACC Heart Failure · 被引 13)
- Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF (2024 · Circulation Heart Failure · 被引 10)
- Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status (2024 · JACC Heart Failure · 被引 9)